Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zolbetuximab by Astellas Pharma for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
Zolbetuximab is under clinical development by Astellas Pharma and currently in Phase II for Metastatic Adenocarcinoma of The Pancreas. According...
Zolbetuximab by Astellas Pharma for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Zolbetuximab is under clinical development by Astellas Pharma and currently in Pre-Registration for Adenocarcinoma Of The Gastroesophageal Junction. According to...
Zolbetuximab by Astellas Pharma for Gastric Cancer: Likelihood of Approval
Zolbetuximab is under clinical development by Astellas Pharma and currently in Pre-Registration for Gastric Cancer. According to GlobalData, Pre-Registration drugs...